Access cutting-edge malignant glioma treatment through this clinical trial at a research site in Edison. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Edison location
Access malignant glioma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related malignant glioma treatment provided free
Check if you qualify for this malignant glioma clinical trial in Edison, NJ
No-Cost Study Care
Local to Edison
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
An open label, non-randomized study in pediatric patients with advanced high-grade gliomas and other solid tumors. The study will be performed in two phases: a dose escalation phase in up to 18 patients following a standard "3+3" design to establish dose-limiting toxicity (DLT) and a "safe" dose of LAM561 followed by an expanded safety cohort of up to 10 patients treated at the Maximum Tolerated Dose (MTD). If the MTD is well tolerated in the expanded safety cohort, that dose becomes the Recomm
Sponsor: Laminar Pharmaceuticals
Yes, this clinical trial (NCT04299191) has an active research site in Edison, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for malignant glioma treatment options in Edison, NJ, this clinical trial (NCT04299191) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Edison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant glioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all malignant glioma clinical trials near you to find additional studies recruiting in your area.
See all brain cancer clinical trials recruiting in Edison — not just this study.
Browse Brain Cancer Trials in Edison →